Literature DB >> 14175647

MULTIPLE MYELOMA. II. ANALYSIS OF CYCLOPHOSPHAMIDE THERAPY IN 165 PATIENTS.

D R KORST, G O CLIFFORD, W M FOWLER, J LOUIS, J WILL, H E WILSON.   

Abstract

Entities:  

Keywords:  BLOOD PROTEIN ELECTROPHORESIS; CLINICAL RESEARCH; CYCLOPHOSPHAMIDE; DRUG THERAPY; MULTIPLE MYELOMA

Mesh:

Substances:

Year:  1964        PMID: 14175647

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Cyclophosphamide in the treatment of myelomatosis.

Authors:  O S Choi; A English; J H Hilton; G E Catton; M D Brown
Journal:  Can Med Assoc J       Date:  1967-11-04       Impact factor: 8.262

2.  [The therapy of the paraproteinemias].

Authors:  U Kanzow
Journal:  Blut       Date:  1969-05

3.  Management of multiple myeloma.

Authors:  J S Malpas
Journal:  Br Med J       Date:  1969-04-19

4.  Treatment of myelomatosis with fluoride.

Authors: 
Journal:  Br Med J       Date:  1967-04-15

5.  [Life prognosis of treated and non-treated patients with plasmacytoma].

Authors:  C Ramsbott; H Gerhartz; P Obrecht
Journal:  Blut       Date:  1967-01

6.  Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.

Authors:  D E Bergsagel; D H Cowan; R Hasselback
Journal:  Can Med Assoc J       Date:  1972-11-04       Impact factor: 8.262

7.  Peptichemio induction therapy in myelomatosis.

Authors:  G Merlini; P G Gobbi; A Riccardi; G Riva; C Sardi; S Perugini
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Multiple myeloma. Clinical correlation of immunoglobulin changes with therapy. A report of 23 cases.

Authors:  C M Basch; E H Rosenbaum
Journal:  Calif Med       Date:  1969-01

9.  Combination therapy for myelomatosis.

Authors:  L Azam; I W Delamore
Journal:  Br Med J       Date:  1974-12-07

Review 10.  Fact or fiction--identifying the elusive multiple myeloma stem cell.

Authors:  Joshua Kellner; Bei Liu; Yubin Kang; Zihai Li
Journal:  J Hematol Oncol       Date:  2013-12-07       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.